June 23, 2020 / 10:01 AM / 11 days ago

BRIEF-Shandong Xinhua Pharmaceutical Proposes To Enter Investment Agreement With Lianren Health Medical Big Data Technology

June 23 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :

* SHANDONG XINHUA PHARMACEUTICAL- PROPOSES TO ENTER INTO AN INVESTMENT AGREEMENT WITH LIANREN HEALTH MEDICAL BIG DATA TECHNOLOGY CO

* SHANDONG XINHUA PHARMACEUTICAL- AGREEMENT ALSO WITH OTHER INVESTORS INCLUDING YINFENG XINBAI, SHANDONG DEVELOPMENT AMONG OTHERS

* SHANDONG XINHUA PHARMACEUTICAL- LIANREN HEALTH PROPOSING TO ESTABLISH CO IN PRC WITH REGISTERED CAPITAL OF RMB2.5 BILLION FOR OPERATING BIG DATA CENTRE

* SHANDONG XINHUA PHARMACEUTICAL CO LTD - AGREEMENT TO FORM A LIMITED LIABILITY CO IN PRC

* SHANDONG XINHUA PHARMACEUTICAL-CO TO HAVE 4% STAKE IN NEW CO WITH SUBSCRIPTION AMOUNT OF RMB100 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below